top of page

EUDAMED Device Registration: Basic UDI-DI, UDI-DI Data and Registration Sequence

12 hours ago
10 min read
EUDAMED cihaz kaydı UDI/Cihaz modülü rehberi

SUMMARY

EUDAMED device registration means that, before placing a device on the market, the manufacturer enters the Basic UDI-DI and UDI-DIs of the device, together with the data listed in Annex VI, into the UDI/Device module of EUDAMED. The obligation is in Article 29 of the Medical Device Regulation (MDR).

In this article we explain device registration with verbatim quotations from the regulation articles, Annex VI and the MDCG EUDAMED Q&A document. We covered actor registration in general in our article on EUDAMED registration and devices under the old directives in our article on EUDAMED legacy device registration.

For data entry in your EUDAMED actor and device registrations: Medical Device ÜTS Registration Consultancy

Contents

1. What Is EUDAMED Device Registration?

Two of EUDAMED's electronic systems relate to devices:

  • “a) The electronic system for the registration of devices referred to in the fourth paragraph of Article 29.”

  • “b) The UDI database referred to in Article 28.”

The MDCG Q&A document explains at which level registration is made:

“However, in Eudamed, registration of a device/SPP in the UDI/DEV module means registering a device/SPP at the device identifier level (excluding production identifiers).”

That is, registration is made once per UDI-DI. Production identifiers (UDI-PI) such as lot, serial number and manufacturing date are not registered individually. In Annex VI Part B, only the information on how the production of the device is controlled is entered.

2. Who Registers the Device?

“ARTICLE 29- (1) Before placing a device other than a custom-made device on the market, the manufacturer assigns the device a Basic UDI-DI as defined in Annex VI Part C, in accordance with the rules of the issuing entities referred to in the second paragraph of Article 27, and enters it into the UDI database together with the other core data elements referred to in Annex VI Part B relating to that device.”

For systems or procedure packs (SİP), the same obligation lies with the responsible person who places the pack on the market (Article 29, second paragraph). The role of the authorised representative and importer is not to make the registration but to check it:

“c) To comply with the registration obligations set out in Article 31 and to verify that the manufacturer has complied with the registration obligations set out in Articles 27 and 29.”

“(4) Importers verify that the device has been registered in the electronic system in accordance with Article 29 and add their own details to the registration in accordance with Article 31.”

Custom-made devices are not registered in the UDI/Device module. MDCG Q&A: "Custom-made devices also cannot be registered in the UDI/DEV module." For details, see our page on authorised representative and importer.

3. Actor Registration and SRN First

Before device registration, the manufacturer must be registered as an actor and have received an SRN:

“(3) The manufacturer uses the single registration number when applying to a notified body for conformity assessment and when accessing EUDAMED to fulfil its obligations under Article 29.”

“(2) After verifying the data entered in accordance with the first paragraph, the Authority conveys the single registration number obtained from the electronic system referred to in Article 30 to the manufacturer, authorised representative or importer.”

A manufacturer established in Türkiye does not appoint an authorised representative. TİTCK ÜTS Registration Guideline TCKKD-KLVZ-03:

“d) Manufacturers established in an EU member state or in Türkiye cannot appoint an EU authorised representative. The EU authorised representative requirement exists only for manufacturers not established in an EU member state or in Türkiye.”

An EU Login account linked to a business e-mail address is needed to log in to EUDAMED. The first person who registers the actor becomes the Local Actor Administrator (LAA) once the registration is approved. The EUDAMED user guide translated by TİTCK adds:

“It is good practice for each actor to have at least 2 LAAs (and at least one of them should not belong to a subcontractor).”

For the SRN, see our glossary entry What is an SRN.

4. Basic UDI-DI and UDI-DI

The registration has two keys. The Basic UDI-DI is defined in Annex VI Part C as follows:

“The Basic UDI-DI is the primary identifier of a device model. It is the DI assigned at the level of the unit of use of the device. It is the main key for records in the UDI database and is referenced in relevant certificates and EU declarations of conformity.”

The UDI-DI, according to Article 27, is the manufacturer- and device-specific device identifier:

“1) A UDI device identifier (UDI-DI) specific to the manufacturer and the device, providing access to the information set out in Annex VI Part B,”

According to the MDCG Q&A: "Uniqueness checks are applied in Eudamed when a device is registered." For details of the concepts, see our articles What is a Basic UDI-DI and UDI issuing entities.

5. Information Entered at Basic UDI-DI Level (Annex VI Part A, 2)

“(4) Before placing a device other than a custom-made device on the market, the manufacturer enters into EUDAMED, or confirms if already entered, the information referred to in point 2 of Annex VI Part A, except for point 2.2, and thereafter keeps this information up to date.”

Device information in point 2 of Annex VI Part A:

  • “2.1. Basic UDI-DI,”

  • “2.2. Type, number and expiry date of the certificate issued by the notified body, the name or identification number of that notified body, and the link to the information in the certificate entered by the notified body in the electronic system on notified bodies and certificates,”

  • “2.3. Türkiye / EU member states in which the device is to be or has been placed on the market,”

  • “2.4. In the case of class IIa, class IIb or class III devices, the Türkiye / EU member states in which the device is or is to be made available,”

  • “2.5. Risk class of the device,”

  • “2.6. Reprocessed single-use device (yes/no),”

  • “2.7. Presence of a substance which, if used separately, may be considered to be a medicinal product, and the name of that substance,”

  • “2.8. Presence of a substance which, if used separately, may be considered to be a medicinal product derived from human blood or human plasma, and the name of that substance,”

  • “2.9. Presence of tissues or cells of human origin or their derivatives (yes/no),”

  • “2.10. Presence of tissues or cells of animal origin or their derivatives, as referred to in the Regulation on Medical Devices Manufactured Utilising Animal Tissues (yes/no),”

  • “2.11. Where applicable, the single identification number of the clinical investigation or investigations conducted with regard to the device, or a link to the clinical investigation registration in the electronic system on clinical investigations,”

  • “2.12. In the case of devices listed in Annex XVI, a statement that the intended purpose of the device is non-medical,”

  • “2.13. In the case of devices designed and manufactured by another legal or natural person as referred to in the fifteenth paragraph of Article 10, the name, address and contact details of that legal or natural person,”

  • “2.14. In the case of class III or implantable devices, the summary of safety and clinical performance,”

  • “2.15. Status of the device (on the market / no longer placed on the market / recalled / field safety corrective action initiated).”

The certificate information in 2.2 is excluded from the manufacturer's entry under this paragraph. For devices requiring a notified body, the notified body confirms this information in EUDAMED (see below).

6. Data Entered with the UDI-DI (Annex VI Part B)

Annex VI Part B: "The manufacturer enters into the UDI database, together with the UDI-DI, all of the following information on the manufacturer and the device:"

  • “1. Quantity per package configuration,”

  • “2. The Basic UDI-DI as referred to in Article 29 and any additional UDI-DIs,”

  • “3. The way in which production of the device is controlled (expiry date or manufacturing date, lot number, serial number)”

  • “5. Name and address of the manufacturer (as indicated on the label),”

  • “6. The single registration number (SRN) issued in accordance with the second paragraph of Article 31,”

  • “7. Where applicable, name and address of the authorised representative (as indicated on the label),”

  • “8. Medical device nomenclature code as referred to in Article 26,”

  • “9. Risk class of the device,”

  • “10. Name or trade name of the device,”

  • “11. Device model, reference or catalogue number”

  • “12. Where applicable, clinical size, including volume, length, gauge, diameter,”

  • “13. Additional product description (optional),”

  • “14. Where applicable, storage and/or handling conditions (as indicated on the label or in the instructions for use),”

  • “15. Where applicable, additional trade names of the device,”

  • “16. Labelled as a single-use device (yes/no),”

  • “17. Where applicable, maximum number of reuses,”

  • “18. Device labelled as sterile (yes/no),”

  • “19. Need for sterilisation before use (yes/no),”

  • “20. Contains latex (yes/no)”

  • “21. Where applicable, information labelled in accordance with point 10.4.5 of Annex I,”

  • “22. URL for additional information, such as electronic instructions for use (optional),”

  • “23. Where applicable, critical warnings or contraindications,”

  • “24. Status of the device (on the market / no longer placed on the market / recalled / field safety corrective action initiated)”

Item 4 of the list is the "unit of use" DI, for cases where the device does not carry a UDI at the unit-of-use level. The terminology in item 8 is EMDN: TCKKD-KLVZ-03 defines EMDN as "the terminology to be used when registering devices in the EUDAMED database and ÜTS". For code selection, see our page on GMDN and EMDN code.

7. Sequence for Devices Requiring a Notified Body

“(3) For devices subject to a conformity assessment referred to in the third paragraph of Article 52 and in points (b) and (c) of the fourth paragraph of Article 52, the assignment of the Basic UDI-DI referred to in the first paragraph of this Article is carried out before the manufacturer applies to a notified body for that assessment.”

“After the relevant certificate has been issued and before the device is placed on the market, the manufacturer enters the Basic UDI-DI into the UDI database together with the other core data elements referred to in Annex VI Part B relating to that device.”

The sequence is: assignment of the Basic UDI-DI, application to the notified body, certificate, then entry into the UDI database. The notified body refers to the Basic UDI-DI in the certificate and confirms the accuracy of the information in Annex VI Part A 2.2 in EUDAMED. The note in the MDCG Q&A:

“Note: When submitting all required device information in the UDI/DEV module, the manufacturer has fulfilled its obligations on device registration under MDR Article 29 and IVDR Article 26. For certain devices, UDI and device data will become publicly available only after the NB has entered the relevant product certificate information in the NB/CRF module.”

8. Mandatory Use and Transitional Periods

With Regulation (EU) 2024/1860, the EUDAMED modules become mandatory one by one. According to Article 111 of the Medical Device Regulation, the provisions including Article 29 enter into force on:

“6 months after the date on which the notice stating that the relevant electronic system is functional and meets the functional specifications is published in the Official Journal of the European Union,”

For devices that started to be placed on the market before this date, the seventeenth paragraph of provisional Article 1 grants an additional period:

“a) Manufacturers shall ensure that the information required to be entered in Eudamed under Article 29 is entered in the electronic system referred to in points (a) and (b) of the second paragraph of Article 33 no later than 12 months from the date of publication of the notice referred to in point (a) of the first paragraph of Article 111, including for the following devices provided that they are placed on the market within 6 months from the date of publication of that notice:”

For certificates, the period is given to notified bodies:

“b) Notified bodies, no later than 18 months from the date of publication of the notice referred to in point (a) of the first paragraph of Article 111 relating to the electronic system referred to in point (ç) of the second paragraph of Article 33,”

For a device placed on the market for the first time after the mandatory date, the rule is clear. MDCG Q&A:

“Where the first individual (sales) unit of a Regulation device with a given UDI-DI (excluding custom-made devices, investigational devices and devices for performance studies, which do not need to be registered in the UDI/DEV module) or of an SPP is placed on the EU market on or after the date of mandatory use of the UDI/DEV module, the relevant device registration in the UDI/DEV module must be made before the first individual unit is placed on the EU market.”

For these deadlines set out as a calendar, see our page on EUDAMED UDI and device registration deadline.

9. Does EUDAMED Registration Replace ÜTS Registration?

No. Article 34 of the Medical Device Regulation keeps the two obligations separate:

“(1) Without prejudice to the obligations relating to EUDAMED set out in this Regulation, economic operators established in Türkiye, notified bodies, healthcare institutions, healthcare professionals and other relevant persons fulfil their obligations relating to the national product tracking system for medical devices (ÜTS).”

For device registration in ÜTS, see our page on ÜTS product registration.

10. Frequently Asked Questions

Can the importer make the EUDAMED device registration?

According to the regulation, the manufacturer enters the Basic UDI-DI and the Annex VI data into the UDI database. The importer verifies that the device has been registered and adds its own information to the registration.

Are lot and serial numbers entered in EUDAMED?

No. Registration is at the device identifier (UDI-DI) level, excluding production identifiers. In Annex VI Part B, only the way production is controlled (expiry or manufacturing date, lot, serial number) is selected.

Is actor registration required before device registration?

Yes. The manufacturer uses the SRN when accessing EUDAMED for its obligations under Article 29. The SRN is conveyed after the data in the actor registration has been verified.

Does a manufacturer in Türkiye need to appoint an EU authorised representative for EUDAMED?

No. According to TCKKD-KLVZ-03, manufacturers established in an EU member state or in Türkiye cannot appoint an EU authorised representative.

When is the Basic UDI-DI assigned for a device requiring a notified body?

Before applying to the notified body. The device data is entered into the UDI database after the certificate has been issued and before the device is placed on the market.

For EUDAMED actor registration and Basic UDI-DI and UDI-DI data entry: Medical Device ÜTS Registration Consultancy

Sources

 
 

Medical Device ÜTS Registration Consultancy

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara